Andrew Lo, Director at BridgeBio Pharma, Inc. (BBIO), bought 7,500 shares at $12.90 ($99K) on 2021-12-29, disclosed to the SEC on 2022-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.90 | 6,000 | $77K | 78.3% |
| 2 | $14.30 | 1,500 | $21K | 21.7% |
| Total | $13.18 avg | 7,500 | $99K | 100% |
| Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |